Levulinic Acid

Levulinic Acid

SCHEMBL408016

CC(=O)CCC(=O)O.OCC(O)COCC(O)CO

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
SLC15A2 Q16348 1/20 0.54
USP2 O75604 1/20 0.39
KDM4E B2RXH2 3/20 0.39
DUSP3 P51452 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.39
EGLN1 Q9GZT9 3/20 0.38
KDM2A Q9Y2K7 3/20 0.38
KDM6B O15054 2/20 0.38
KDM5C P41229 2/20 0.38
PHF8 Q9UPP1 2/20 0.38
ALKBH5 Q6P6C2 1/20 0.35
SUCNR1 Q9BXA5 1/20 0.35
DGKA P23743 1/20 0.33
FAAH O00519 2/20 0.32
FFAR4 Q5NUL3 1/20 0.32
FFAR1 O14842 1/20 0.32
PLA2G2C Q5R387 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Levulinic Acid SCHEMBL402503 0.86 LMNA (0.67) LMNASLC15A2KDM4EALDH1A1EGLN1
Levulinic Acid SCHEMBL28366988 0.86 LMNA (0.67) LMNASLC15A2KDM4EALDH1A1EGLN1
Levulinic Acid SCHEMBL29200968 0.85 CA1 (0.45) LMNASLC15A2USP2KDM4EDUSP3
Acetic Acid SCHEMBL27310521 0.83 USP2 (0.47) LMNAUSP2KDM4EDUSP3MEN1
Butyric Acid SCHEMBL8160401 0.82 FFAR3 (0.52) LMNAUSP2KDM4EDUSP3MEN1
SCHEMBL8488063 0.80 USP2 (0.50) LMNAUSP2KDM4EDUSP3MEN1
Succinic Acid SCHEMBL27929020 0.78 LMNA (0.47) LMNASLC15A2USP2KDM4EDUSP3
SCHEMBL26008133 0.78 LMNA (0.51) LMNAUSP2KDM4EDUSP3MEN1
SCHEMBL18115160 0.78 USP2 (0.47) LMNAUSP2KDM4EDUSP3MEN1
SCHEMBL408015 0.78 PRKCA (0.45) LMNAUSP2KDM4EDUSP3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906961-B2 Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom SEGETIS, INC. (US) 2014-12-09 US disclosed
US-20130303648-A1 GLYCEROL LEVULINATE KETALS AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES, AND POLYURETHANES FORMED THEREFROM GFBIOCHEMICALS LIMITED (MT) 2013-11-14 US disclosed
US-8492433-B2 Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom SEGETIS, INC. (US) 2013-07-23 US disclosed
EP-1954140-B1 GLYCEROL LEVULINATE KETALS AND THEIR USE SEGETIS INC (US) 2013-05-29 EP disclosed
US-20120196947-A1 GLYCEROL LEVULINATE KETALS AND THEIR USE IN THE MANUFACTURE OF POLYURETHANES, AND POLYURETHANES FORMED THEREFROM SEGETIS, INC. (US) 2012-08-02 US disclosed
US-8178701-B2 Glycerol levulinate ketals and their use SEGETIS, INC. (US) 2012-05-15 US disclosed
US-20120021962-A1 GLYCEROL LEVULINATE KETALS AND THEIR USE SEGETIS, INC. (US) 2012-01-26 US disclosed
US-8053468-B2 Glycerol levulinate ketals and their use SEGETIS, INC. (US) 2011-11-08 US disclosed
US-20080242721-A1 plasticizers; polylactones and polyurethanes prepared from them; substituted oxymethylene moiety attached to the dioxolane ring is predominantly in the cis configuration relative to the configuration of the side chain bearing the carboxyl group AROMAGEN CORPORATION (US) 2008-10-02 US disclosed
EP-1954140-A2 GLYCEROL LEVULINATE KETALS AND THEIR USE Aromagen Corporation (US) 2008-08-13 EP disclosed
WO-2007062118-A2 GLYCEROL LEVULINATE KETALS AND THEIR USE AROMAGEN CORPORATION (US) 2007-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242721-A1 plasticizers; polylactones and polyurethanes prepared from them; substituted oxymethylene moiety attached to the dioxolane ring is predominantly in the cis configuration relative to the configuration of the side chain bearing the carboxyl group GK, FTO, DGKK LMNA 1816/4885SLC15A2 2452/4885USP2 351/4885
US-20120021962-A1 GLYCEROL LEVULINATE KETALS AND THEIR USE GK, GRIK5, KHK LMNA 2269/4885SLC15A2 1322/4885USP2 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.